Edition:
United States

Abaxis Inc (ABAX.OQ)

ABAX.OQ on NASDAQ Stock Exchange Global Select Market

44.41USD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$44.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,913
52-wk High
$55.95
52-wk Low
$43.66

Summary

Name Age Since Current Position

Clinton Severson

69 2015 Chairman of the Board, Chief Executive Officer

Donald Wood

65 2015 President, Chief Operating Officer

Ross Taylor

53 2015 Chief Financial Officer, Vice President - Finance, Secretary

Kenneth Aron

64 2008 Chief Technology Officer

Craig Tockman

57 2014 Vice President - Animal Health Sales and Marketing for North America

Achim Henkel

59 2008 Managing Director of Abaxis Europe GmbH

Vernon Altman

71 2014 Lead Independent Director

Richard Bastiani

74 1995 Independent Director

Michael Casey

71 2010 Independent Director

Henk Evenhuis

74 2002 Independent Director

Prithipal Singh

78 1992 Independent Director

Biographies

Name Description

Clinton Severson

Mr. Clinton H. Severson is Chairman of the Board, Chief Executive Officer of the Company. From June 1996 until April 2015, Mr. Severson also served as our President. From February 1989 to May 1996, Mr. Severson served as President and Chief Executive Officer of MAST Immunosystems, Inc., a privately-held medical diagnostic company. Since January 2015, Mr. Severson has served on the Board of Directors of Cutera. Since June 2011, Mr. Severson has served on the Board of Directors of Response Biomedical Corporation. From November 2008 to November 2016, Mr. Severson served on the Board of Directors of Trinity Biotech, a biotechnology company, prior to its acquisition. From November 2006 to February 2012, Mr. Severson served on the Board of Directors of CytoCore, Inc., a biotechnology company. Mr. Severson is also a member of the Board of Directors of a privately-held company.

Donald Wood

Mr. Donald Peter Wood is President, Chief Operating Officer of the Company. Mr. Wood joined us in October 2007 as Vice President of Operations, served as Chief Operations Officer from April 2009 to April 2014 and served as Chief Operating Officer from April 2014 to April 2015. From April 2003 to September 2007, Mr. Wood was the Vice President of Operations of Cholestech Corporation, a medical products manufacturing company that was subsequently acquired by Inverness Medical Innovations, Inc. in September 2007. From July 2001 to March 2003, Mr. Wood served as Vice President of Bone Health, a business unit of Quidel Corporation, a manufacturing and marketer of point-of-care diagnostics, and was responsible for Bone Health Product Operations, Device Research and Development, and Sales and Marketing. He also served as Quidel’s Vice President of Ultrasound Operations from August 1999 to July 2001. From July 1998 to August 1999, Mr. Wood was the Director of Ultrasound Operations for Metra Biosystems Inc., a developer and manufacturing company of point-of-care products for osteoporosis, prior to Quidel’s acquisition of Metra Biosystems Inc.

Ross Taylor

Mr. Ross Taylor is a Chief Financial Officer, Vice President - Finance, Secretary of the Company., effective August 2015. Mr. Taylor joined us in October 2014 as Vice President of Business Development and Investor Relations. From 2005 to 2014, Mr. Taylor served as Senior Vice President, Equity Research Analyst at CL King & Associates, an investment banking firm.

Kenneth Aron

Dr. Kenneth P. Aron, Ph.D., is a Chief Technology Officer of the Company. Dr. Aron joined us in February 2000 as Vice President of Research and Development. From April 1998 to November 1999, Dr. Aron was Vice President of Engineering and Technology of Incyte Pharmaceuticals, a genomic information company. From April 1996 to April 1998, Dr. Aron was Vice President of Research, Development and Engineering for Cardiogenesis Corporation, a manufacturer of laser-based cardiology surgical products.

Craig Tockman

Dr. Craig M. Tockman is Vice President - Animal Health Sales and Marketing for North America of the Company. Dr. Tockman joined in June 2006 as Director of Professional Services and was promoted to Director of Field Operations in October 2013. From 2003 to 2006, Dr. Tockman served on Abaxis’ Advisory Board since he joined in 2003 as a founding member.

Achim Henkel

Mr. Achim Henkel is Managing Director of Abaxis Europe GmbH, subsidiary of the Company., since its incorporation in 2008. From January 2000 to June 2008, Mr. Henkel served as our Sales and Marketing Manager for Europe, the Middle East and Africa. Starting in October 2014, Mr. Henkel has also served as our Sales and Marketing Manager for Asia. From January 1998 to December 2000, Mr. Henkel served as a consultant to Abaxis.

Vernon Altman

Mr. Vernon Edward Altman is an Lead Independent Director of the Company. Mr. Altman joined the founding group to start Bain & Company, a global business consulting firm, in 1973 and is currently Senior Advisor of Bain & Company. Mr. Altman is Chairman of the Board of Directors of Vobile, Inc. He also served on the Board of Directors of Napster, Inc. prior to its acquisition.

Richard Bastiani

Dr. Richard J. Bastiani, Ph.D., is an Independent Director of the Company. Dr. Bastiani is currently retired. Dr. Bastiani was President of Dendreon, a biotechnology company, from September 1995 to September 1998. From 1971 until 1995, Dr. Bastiani held a number of positions with Syva Company, a diagnostic company, including as President from 1991 until Syva was acquired by a subsidiary of Hoechst AG of Germany in 1995. From 2007 to 2011, Dr. Bastiani served as Chairman of the Board of Directors of Response Biomedical Corporation. From 1998 to 2005, Dr. Bastiani served as Chairman of the Board of Directors of ID Biomedical Corporation, after he was appointed to the Board of Directors of ID Biomedical Corporation in October 1996. Dr. Bastiani is also a member of the Board of Directors of three privately-held companies.

Michael Casey

Mr. Michael D. Casey is an Independent Director of the Company. Mr. Casey is currently retired. From September 1997 to February 2002, Mr. Casey served as the Chairman, President, Chief Executive Officer and a director of Matrix Pharmaceutical, Inc., a biotechnology company. From November 1995 to September 1997, Mr. Casey was Executive Vice President at Schein Pharmaceutical, Inc., a biotechnology company. From December 1996 to September 1997, he also served as President of the retail and specialty products division of Schein Pharmaceutical, Inc. From June 1993 to November 1995, he served as President and Chief Operating Officer of Genetic Therapy, Inc., a biotechnology company. Mr. Casey was President of McNeil Pharmaceutical (a unit of Johnson & Johnson) from 1989 to June 1993 and Vice President, Sales and Marketing for Ortho Pharmaceutical Corp. (a subsidiary of Johnson & Johnson) from 1985 to 1989. Mr. Casey has served on the Board of Directors of Celgene Corporation since 2002. Mr. Casey previously served on the Board of Directors of AVI Biopharma, Inc. (now known as Sarepta Therapeutics, Inc.) from 2006 to 2010, Allos Therapeutics, Inc. from 2002 to 2010, Cholestech Corporation from 2001 to 2007, OrthoLogic Corporation from 2004 to 2007, Sicor, Inc. from 2002 to 2004, Bone Care International, Inc. from 2001 to 2005 and Durect Corp. from 2004 to 2013.

Henk Evenhuis

Mr. Henk J. Evenhuis is an Independent Director of the Company. Mr. Evenhuis is currently retired. Mr. Evenhuis served as Executive Vice President and Chief Financial Officer of Fair Isaac Corporation, an analytic software company, from October 1999 to October 2002. From 1987 to 1998, he was Executive Vice President and Chief Financial Officer of Lam Research Corporation, a semiconductor equipment manufacturer. He served on the Board of Directors of Credence Systems Corporation from 1993 to 2008. Mr. Evenhuis was selected as a director because of his financial expertise and prior senior leadership experience as a Chief Financial Officer at global technology companies, as well as his experience serving on the boards of various public companies, which provides a strong foundation to serve as Chairman of the Audit Committee.

Prithipal Singh

Dr. Prithipal Singh, Ph.D., is an Independent Director of the Company. Dr. Singh is currently retired. Prior to retiring, Dr. Singh was the Founder, Chairman and Chief Executive Officer of ChemTrak Inc., a manufacturer of medical diagnostic equipment, from 1988 to 1998. Dr. Singh was an Executive Vice President of Idetec Corporation, an animal health care company, from 1985 to 1988 and a Vice President of Syva Corporation, a diagnostic company, from 1977 to 1985.

Basic Compensation

Name Fiscal Year Total

Clinton Severson

4,432,070

Donald Wood

1,955,910

Ross Taylor

1,786,640

Kenneth Aron

1,828,280

Craig Tockman

1,828,170

Achim Henkel

2,044,750

Vernon Altman

277,970

Richard Bastiani

280,470

Michael Casey

272,970

Henk Evenhuis

283,470

Prithipal Singh

276,970
As Of  30 Mar 2017